Skip to main content
SpringerLink
Log in

Symptomatic and hemodynamic benefit of pentaerythrityl tetranitrate and hydralazine in a case of congestive heart failure

  • Clinical Correspondence
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Bitar F, Akhter MW, Khan S, Singh H, Elkayam U (2004) Survey of the use of organic nitrates for the treatment of chronic congestive heart failure in the United States. Am J Cardiol 94:1465–1468

    Article  PubMed  CAS  Google Scholar 

  2. Daiber A, Oelze M, Coldewey M et al (2005) Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure. Biochem Biophys Res Commun 338:1865–1874

    Article  PubMed  CAS  Google Scholar 

  3. Elkayam U, Bitar F (2005) Effects of nitrates and hydralazine in heart failure: clinical evidence before the African American heart failure trial. Am J Cardiol 96:37i–43i

    Article  PubMed  CAS  Google Scholar 

  4. Taylor AL, Ziesche S, Yancy C et al (2004) Combination of isosorbide dinitrate and hydralazine in Blacks with heart failure. N Engl J Med 351:2049–2057

    Article  PubMed  CAS  Google Scholar 

  5. Mullens W, Abrahams Z, Francis GS et al (2009) Usefulness of isosorbide dinitrate and hydralazine as add-on therapy in patients discharged for advanced decompensated heart failure. Am J Cardiol 103:1113–1119

    Article  PubMed  CAS  Google Scholar 

  6. Gori T, Parker JD (2008) Nitrate-induced toxicity and preconditioning: a rationale for reconsidering the use of these drugs. J Am Coll Cardiol 52:251–254

    Article  PubMed  CAS  Google Scholar 

  7. Daiber A, Wenzel P, Oelze M, Munzel T (2008) New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance. Clin Res Cardiol 97:12–20

    Article  PubMed  CAS  Google Scholar 

  8. Gori T, Daiber A (2009) Non-hemodynamic effects of organic nitrates and the distinctive characteristics of pentaerithrityl tetranitrate. Am J Cardiovasc Drugs 9:7–15

    PubMed  CAS  Google Scholar 

  9. Cohn JN, Tam SW, Anand IS, Taylor AL, Sabolinski ML, Worcel M (2007) Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated Black population with heart failure: results from A-HeFT. J Card Fail 13:331–339

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 2. Medizinische Klinik, Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Germany

    Tommaso Gori & Thomas Münzel

Authors
  1. Tommaso Gori
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas Münzel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tommaso Gori.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gori, T., Münzel, T. Symptomatic and hemodynamic benefit of pentaerythrityl tetranitrate and hydralazine in a case of congestive heart failure. Clin Res Cardiol 98, 677–679 (2009). https://doi.org/10.1007/s00392-009-0053-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-009-0053-x

Keywords

Search

Navigation